Triciribine, also known as API-2, suppresses the phosphorylation level and kinase activity of Akt. Akt kinase inhibition has been shown to induce apoptosis and cell growth in cancer cell research. Triciribine can selectively inhibit Akt1, Akt2, and Akt3 without inhibiting known upstream activators,PDK1 and PI 3-Kinase, of Akt. Studies show that Triciribine in duces apoptosis and inhibits cell growth in cells that express atypical Akt1. Additionally, Triciribine has antineoplastic and antiviral activity at low micromolar and submicromolar concentrations, and has been demonstrated to inhibit incorporation of amino acids into proteins and purine nucleotide synthesis.
. Moore, E.C., et al. 1989. Biochem. Pharmacol. 38: 4037-4044. PMID: 2480791
2. Porcari, A.R., et al. 2000. J. Med. Chem. 43: 2438-2448. PMID: 10882371
3. Yang, L., et al. 2004. Cancer Res. 64: 4394-4399. PMID: 15231645
See how others have used Triciribine. Click on the entry to view the PubMed entry .
PMID: # 27864646
Yan, X. et al. 2017. Low-level laser irradiation modulates brain-derived neurotrophic factor mRNA transcription through calcium-dependent activation of the ERK/CREB pathway. Lasers Med Sci. 32: 169-180.
PMID: # 27563247
Jiang, Z. et al. 2016. Oncogenic NanogP8 expression regulates cell proliferation and migration through the Akt/mTOR signaling pathway in human gastric cancer - SGC-7901cell line. Onco Targets Ther. 9: 4859-66.
PMID: # 26948085
Fu, T. et al. 2016. Hyperoside induces both autophagy and apoptosis in non-small cell lung cancer cells in vitro. Acta Pharmacol. Sin.. 37: 505-18.
PMID: # 26159930
Feng, J. et al. 2015. Photoactivation of TAZ via Akt/GSK3β signaling pathway promotes osteogenic differentiation. Int. J. Biochem. Cell Biol.. 66: 59-68.
PMID: # 23946409
Meng, C. et al. 2013. Low-level laser therapy rescues dendrite atrophy via upregulating BDNF expression: implications for Alzheimer's disease. J. Neurosci.. 33: 13505-17.
PMID: # 24023668
Liu, L. et al. 2013. Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells. PLoS ONE. 8: e73038.
PMID: # 23065720
Huang, L. et al. 2013. Activation of nuclear estrogen receptors induced by low-power laser irradiation via PI3-K/Akt signaling cascade. J. Cell. Physiol.. 228: 1045-59.
PMID: # 22326662
Feng, J. et al. 2012. Low-power laser irradiation (LPLI) promotes VEGF expression and vascular endothelial cell proliferation through the activation of ERK/Sp1 pathway. Cell. Signal.. 24: 1116-1125.
PMID: # 22228808
Diraimondo, TR. et al. 2012. Interferon-γ activates transglutaminase 2 via a phosphatidylinositol-3-kinase-dependent pathway: implications for celiac sprue therapy. J. Pharmacol. Exp. Ther.. 341: 104-14.
PMID: # 22917976
Liang, J. et al. 2012. Photobiomodulation by low-power laser irradiation attenuates Aβ-induced cell apoptosis through the Akt/GSK3β/β-catenin pathway. Free Radic. Biol. Med.. 53: 1459-67.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2017 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.